Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
International Journal of Clinical Oncology|July 18, 2025
The nationwide survey of Japanese public opinion about off-label use of anticancer drugs recommended by comprehensive genomic profilingJunichi Matsubara, Kumi Mukai, Manabu MutoGan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[Precision Medicine Provided by National Health Insurance]Manabu Muto, Tomohiro Kondo, Junichi Matsubara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 16, 2021
[From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology]Manabu Muto, Tomohiro Kondo, Masahiro Yoshioka, et al.Cancer Science|April 12, 2025
First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx StudyJunichi Matsubara, Kumi Mukai, Tomohiro Kondo, et al.JAMA Network Open|July 17, 2023
First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy OpportunitiesJunichi Matsubara, Kumi Mukai, Tomohiro Kondo, et al.Esophagus : Official Journal of the Japan Esophageal Society|January 20, 2022
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS studyYukiko Mori, Osamu Kikuchi, Takahiro Horimatsu, et al.International Orthopaedics|December 31, 2015
A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral headYutaka Kuroda, Ryuta Asada, Kazutaka So, et al.Pageof 1